Trial Profile
Phase 3 study of OCU-300 in patients with dry eyes
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2016 New trial record